Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

Experience with preoperative therapy for other cancers has led to an assumption that borderline resectable pancreatic cancers can be converted to resectable cancers with preoperative therapy. In this study, the authors sought to determine the rate at which neoadjuvant therapy is associated with a reduction in the size or stage of borderline resectable tumors.

[1]  Jeffrey E. Lee,et al.  Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma , 2012, Cancer.

[2]  Jeffrey E. Lee,et al.  Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[3]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[4]  C. Compton,et al.  Exocrine and Endocrine Pancreas , 2012 .

[5]  J. Gérard,et al.  Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials. , 2012, Critical reviews in oncology/hematology.

[6]  Jeffrey E. Lee,et al.  Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy , 2012, Annals of Surgical Oncology.

[7]  J. Tomlinson,et al.  Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery. , 2011, Archives of surgery.

[8]  Pierre Michel,et al.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. , 2011, The New England journal of medicine.

[9]  Laura H. Tang,et al.  Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease , 2011, Annals of Surgical Oncology.

[10]  Jeffrey E. Lee,et al.  Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer , 2011, Journal of Gastrointestinal Surgery.

[11]  Jeffrey E. Lee,et al.  Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here? , 2011, Annals of Surgical Oncology.

[12]  G. Weiss,et al.  Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer , 2011, Annals of Surgical Oncology.

[13]  J. Tokar,et al.  Defining Venous Involvement in Borderline Resectable Pancreatic Cancer , 2010, Annals of Surgical Oncology.

[14]  Tibor Schuster,et al.  Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages , 2010, PLoS medicine.

[15]  R. Abrams,et al.  Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement , 2009, Annals of Surgical Oncology.

[16]  Kenneth J. Chang,et al.  Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement , 2009, Annals of Surgical Oncology.

[17]  G. La Torre,et al.  A Systematic Review of Resectability and Survival After Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer , 2009, Annals of Surgical Oncology.

[18]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[19]  Jeffrey E. Lee,et al.  Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. , 2008, Journal of the American College of Surgeons.

[20]  Douglas B. Evans,et al.  Development of an Integrated Biospecimen Bank and Multidisciplinary Clinical Database For Pancreatic Cancer , 2008, Annals of Surgical Oncology.

[21]  Jeffrey E. Lee,et al.  Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy , 2006, Annals of Surgical Oncology.

[22]  G. Hortobagyi,et al.  Breast conservation after neoadjuvant chemotherapy , 2005, Cancer.

[23]  Hong-Jin Kim,et al.  Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? , 2002, Journal of Gastrointestinal Surgery.

[24]  F. Ames,et al.  Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.